StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

Reviva Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Reviva Pharmaceuticals's price to book ratio was 0.4× on Oct 19, 2026, against 51.7× a year earlier. Over the last 4 years it ranged from 0.3× to 83.6×, with a median of 4.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.4×−5.7
2025Dec 31, 20256.1×−9.3
2024Apr 30, 202415.3×−46.3
2023Jul 31, 202361.6×+56.5
2022Dec 30, 20225.1×+3.8
2021Dec 31, 20211.2×−3.8
2020Dec 31, 20205.0×–

More Reviva Pharmaceuticals figures

See a number that looks wrong?